Skip to main content
. 1996 May 15;16(10):3311–3321. doi: 10.1523/JNEUROSCI.16-10-03311.1996

Fig. 5.

Fig. 5.

Parvalbumin immunostaining in AD cases.AD, Distribution of parvalbumin immunostaining at pathological levels 1–4, respectively. Note the eventual complete disappearance of immunolabel in layer II and the consequent reduction on the size of the band of immunoreactivity in layer IIIb. Scale bar, 250 μm.